✦ LIBER ✦

Acute and late morbidity in patients with bladder carcinoma treated with ARCON (Accelerated Radiotherapy, Carbogen and Nicotinamide)

✍ Scribed by P.J. Hoskin; A.M. Rojas; H. Phillips; M.I. Saunders

Book ID: 118606625
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 328 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81308-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute and late morbidity in the treatmen

Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide

✍ Peter J. Hoskin; Ana M. Rojas; Heather Phillips; Michele I. Saunders 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

Accelerated radiotherapy with carbogen a

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas

✍ Ph. Lambin; Ph. Poortmans; J. Menten; H.P. Hamers 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Radiotherapy With Concurrent Carbogen an

Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma

✍ Hoskin, P. J.; Rojas, A. M.; Bentzen, S. M.; Saunders, M. I. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 178 KB

Hypoxic radiosensitizers in radical radi

Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma : Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide

✍ Peter J. Hoskin; Michelle I. Saunders; Stanley Dische 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## BACKGROUND. In animal models carbogen (normobaric 95% oxygen, 5% carbon dioxide) provides significant enhancement of local tumor control with fractionated radiotherapy. This approach to radiosensitization has been evaluated in the treatment of patients with bladder carcinoma using radical radiot

30 A multicenter, randomized, phase III

30 A multicenter, randomized, phase III clinical trial with accelerated radiotherapy plus carbogen and nicotinamide (ARCON) in clinical stage T2–4 laryngeal carcinoma: Patient Treatment

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 156 KB

ARCON: accelerated radiotherapy with car

ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC

✍ Jacques Bernier; Juliana Denekamp; Anamaria Rojas; Mauro Trovò; Jean-Claude Hori 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 96 KB